Read Our Latest Issue Newly discovered genetic mutations are providing clues about how this disorder relentlessly destroys motor neurons and robs people of their mobility. The findings may lead to drug therapies for a condition that has long defied treatment Amyotrophic lateral sclerosis (ALS) strikes without warning. The condition, which strips nerve cells of their ability to interact with the body's muscles, starts painlessly, with subtle initial symptoms--such as stumbling, increased clumsiness and slurred speech--that are often overlooked. The disease itself attracted little public attention until legendary New York Yankees first baseman Lou Gehrig began dropping balls and collapsing on the field for no apparent reason. Known as the Iron Horse for playing in 2,130 consecutive games over 14 years, Gehrig was diagnosed with ALS in June 1939 and delivered a poignant farewell at Yankee Stadium the next month. Gehrig's loss of muscle control progressed so rapidly that by December he was too weak to attend his National Baseball Hall of Fame induction. Creeping paralysis eventually left him bedridden. He died in June 1941 at the age of 37. This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover new insights into neuroscience, human behavior and mental health with Scientific American Mind. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.